The aim of this study was to investigate the impact of patient and lesion complexity on outcomes with newer-generation zotarolimus-eluting stents (ZES) and everolimus-eluting stents (EES).
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents : a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention) / G.G. Stefanini, P.W. Serruys, S. Silber, A. A. Khattab, R.J. van Geuns, G. Richardt, P. E. Buszman, H. Kelbæk, A.J. van Boven, S. H. Hofma, A. Linke, V. Klauss, W. Wijns, C. Macaya, P. Garot, C. Di Mario, G. Manoharan, R. Kornowski, T. Ischinger, A.L. Bartorelli, P. Gobbens, S. Windecker. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - 57:22(2011 May 31), pp. 2221-2232.
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents : a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention)
A.L. Bartorelli;
2011-05-31
Abstract
The aim of this study was to investigate the impact of patient and lesion complexity on outcomes with newer-generation zotarolimus-eluting stents (ZES) and everolimus-eluting stents (EES).
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
